Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2010-12-09
Summary
Non-interventional study aiming to provide data on the subjective effects of antipsychotic medication assessing subjective well-being and global functioning of patients with Schizophrenia under antipsychotic medication. Moreover it aims to assess their adherence to the treatment and will investigate whether there is any correlation of these factors with the clinical condition of these patients.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Errikos Tzempelikos, Dr · Sismanoglio Hospital, Psychiatric Department, Greece
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- Greece
Study Locations
More Related Trials
-
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
NCT03164876 ·Status: COMPLETED ·Phase: PHASE1
-
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo
NCT00570063 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia
NCT03356639 ·Status: COMPLETED ·Phase: PHASE1
-
Neurophysiological Evaluation of Schizophrenia Patients After Cognitive and Physical Intervention
NCT03899662 ·Status: COMPLETED ·Phase: NA
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
NCT03809325 ·Status: COMPLETED
-
A Trial to Assess the Antipsychotic Efficacy of ITI-007
NCT02282761 ·Status: COMPLETED ·Phase: PHASE3
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia
NCT01634542 ·Status: COMPLETED
-
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
NCT00833456 ·Status: COMPLETED
-
Salutogenic Approach Based Interview With People With Schizophrenia
NCT04740944 ·Status: COMPLETED ·Phase: NA
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
NCT01730768 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients
NCT00999895 ·Status: COMPLETED
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
NCT01009060 ·Status: COMPLETED ·Phase: PHASE2
-
Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study
NCT03434405 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT04092686 ·Status: COMPLETED ·Phase: PHASE3
-
In-Patient Study In Schizophrenic Patients
NCT00197093 ·Status: COMPLETED ·Phase: PHASE1
-
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
NCT00749970 ·Status: COMPLETED